Medicine
Viread 250 mg tablet
Viread 250 mg tablet is a prescription medicine containing Tenofovir disoproxil for oral use, marketed by Gilead Sciences, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store VIREAD tablets and oral powder at 25 °C (77 °F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Tenofovir disoproxil
- Brand
- Viread
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Gilead Sciences
- Manufacturer
- Gilead Sciences
- Origin register
- US FDA, United States
- Storage
- Store VIREAD tablets and oral powder at 25 °C (77 °F), excursions permitted to 15–30 °C (59–86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF07 Tenofovir disoproxil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 January 2012
- Identifiers
- RxCUI 349251, 352050, 1243227 +7DailyMed set ID 33fd6418-fbdc-42ca-a50d-ce2a476a5418NDC 61958-0406Application NDA021356
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, coated in 1 bottle, plastic | 61958-0406-1 | Gilead Sciences | 18 January 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tenofovir disoproxil 250 mg tablet.
Other strengths and forms of Tenofovir disoproxil
Clinical summary
Tenofovir disoproxil is a hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults, among other approved uses. MedsAcross supplies Tenofovir disoproxil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Tenofovir disoproxilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Viread prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Viread: European public assessment report (EPAR) · European Medicines Agency
- Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan): European public assessment report (EPAR) · European Medicines Agency
Need Viread 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.